EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Interaction between Carvacrol and Thymol, Major Compounds of Ptychotis verticillata Essential Oil: Antioxidant, Anti-Inflammatory and Anticancer Activities against Breast Cancer Lines

Mohamed Taibi iD, Amine Elbouzidi iD, Mounir Haddou iD, Abdellah Baraich iD, Douaae Ou-Yahia, Reda Bellaouchi, Ramzi A Mothana iD, Hanan M Al-Yousef iD, Abdeslam Asehraou iD, Mohamed Addi iD, Bouchra El Guerrouj, Khalid Chaabane

Life · 20.08.2024 · 14 (8) · 1037

DOI: 10.3390/life14081037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 20.08.2024. Verfasst von Mohamed Taibi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Ou…. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project number (RSP2024R119), King Saud University, Riyadh, Saudi Arabia., King Saud University, Riyadh, Saudi Arabia..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to evaluate the antioxidant, anti-inflammatory, and anticancer properties of thymol, carvacrol, and their equimolar mixture. Antioxidant activities were assessed using the DPPH, ABTS, and ORAC methods. The thymol/carvacrol mixture exhibited significant synergism, surpassing the individual compounds and ascorbic acid in DPPH (IC50 = 43.82 ± 2.41 µg/mL) and ABTS (IC50 = 23.29 ± 0.71 µg/mL) assays. Anti-inflammatory activity was evaluated by inhibiting the 5-LOX, COX-1, and COX-2 enzymes. The equimolar mixture showed the strongest inhibition of 5-LOX (IC50 = 8.46 ± 0.92 µg/mL) and substantial inhibition of COX-1 (IC50 = 15.23 ± 2.34 µg/mL) and COX-2 (IC50 = 14.53 ± 2.42 µg/mL), indicating a synergistic effect. Anticancer activity was tested on MCF-7, MDA-MB-231, and MDA-MB-436 breast cancer cell lines using the MTT assay. The thymol/carvacrol mixture demonstrated superior cytotoxicity (IC50 = 0.92–1.70 µg/mL) and increased selectivity compared to cisplatin, with high selectivity indices (144.88–267.71). These results underscore the promising therapeutic potential of the thymol/carvacrol combination, particularly for its synergistic antioxidant, anti-inflammatory, and anticancer properties against breast cancer. This study paves the way for developing natural therapies against breast cancer and other conditions associated with oxidative stress and inflammation, leveraging the synergistic effects of natural compounds like thymol and carvacrol.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatoryanticancerantioxidantbreast cancercarvacrolcytotoxicitymixturenatural therapiesselectivitythymol

Autor:innen und Institutionen

  • Laboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.
  • Centre de l'Oriental des Sciences et Technologies de l'Eau et de l'Environnement (COSTEE), Université Mohammed Premier, Oujda 60000, Morocco.
  • Department of Biological Engineering, IUT Saint-Brieuc, University of Rennes, 35000 Rennes, France.
  • Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Mohamed Taibi, Amine Elbouzidi, Mounir Haddou, Abdellah Baraich, Ramzi A Mothana, Hanan M Al-Yousef, Abdeslam Asehraou, Mohamed Addi

Förderung

  • Project number (RSP2024R119), King Saud University, Riyadh, Saudi Arabia.
  • King Saud University, Riyadh, Saudi Arabia.

Zitieren

APA

Taibi, M., Elbouzidi, A., Haddou, M., Baraich, A., Ou-Yahia, D., Bellaouchi, R., Mothana, R. A., Al-Yousef, H. M., Asehraou, A., Addi, M., Guerrouj, B. E., & Chaabane, K. (2024). Evaluation of the Interaction between Carvacrol and Thymol, Major Compounds of Ptychotis verticillata Essential Oil: Antioxidant, Anti-Inflammatory and Anticancer Activities against Breast Cancer Lines. Life, 14(8), 1037. https://doi.org/10.3390/life14081037

Vancouver

Taibi M, Elbouzidi A, Haddou M, Baraich A, Ou-Yahia D, Bellaouchi R, et al. Evaluation of the Interaction between Carvacrol and Thymol, Major Compounds of Ptychotis verticillata Essential Oil: Antioxidant, Anti-Inflammatory and Anticancer Activities against Breast Cancer Lines. Life. 2024;14(8):1037. doi:10.3390/life14081037

BibTeX
@article{Taibi2024,
  author = {Taibi, Mohamed and Elbouzidi, Amine and Haddou, Mounir and Baraich, Abdellah and Ou-Yahia, Douaae and Bellaouchi, Reda and Mothana, Ramzi A and Al-Yousef, Hanan M and Asehraou, Abdeslam and Addi, Mohamed and Guerrouj, Bouchra El and Chaabane, Khalid},
  title = {Evaluation of the Interaction between Carvacrol and Thymol, Major Compounds of Ptychotis verticillata Essential Oil: Antioxidant, Anti-Inflammatory and Anticancer Activities against Breast Cancer Lines},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {1037},
  doi = {10.3390/life14081037}
}
Kostenlos starten →